In Vivo Immunomagnetic Hyperthermia Platform for Any Cell or Virus Having a Target Surface Receptor
AssigneeIVDiagnostics, Inc.
InventorsBin Hong, Brian Markey
Life of this patent
Estimating the term…
Loading patent…
AssigneeIVDiagnostics, Inc.
InventorsBin Hong, Brian Markey
Estimating the term…
The invention is a nano-entity conjugate for use in an in vivo immunomagnetic hyperthermia system for the detection and treatment of any cell or virus having a target surface receptor which encompasses a technology platform that can be used for both real-time monitoring of any cell or virus having a target surface receptor and as a delivery platform for certain types of treatment that are conducive for in vivo applications. The system allows of cell or virus enumeration; cell or virus capture; and cell or virus removal from the patient's circulatory system in-vivo using immunomagnetic hyperthermia. The application of immunomagnetic hyperthermia may actually diminish and eventually stop the progression of cancer and other blood borne or blood affected diseases.
A multi-functional chemically bound nano-entity conjugate comprising of at least:
An axial magnetic field (AMF) generating device comprising:
A device for diagnosis and treatment of cells or viruses having target xenocells comprising:
A system for diagnosis and treatment of target xenocells comprising:
Dependencies are inferred from the claim text.